Kays Financial Advisory Corp ADV lowered its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 4.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,130 shares of the healthcare conglomerate’s stock after selling 294 shares during the quarter. Kays Financial Advisory Corp ADV’s holdings in UnitedHealth Group were worth $1,631,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. Welch Group LLC bought a new position in shares of UnitedHealth Group in the second quarter worth approximately $106,000. FNY Investment Advisers LLC purchased a new position in shares of UnitedHealth Group during the third quarter valued at approximately $106,000. Blue Chip Partners Inc. purchased a new position in shares of UnitedHealth Group during the second quarter valued at approximately $107,000. Fort L.P. purchased a new position in shares of UnitedHealth Group during the second quarter valued at approximately $119,000. Finally, Polaris Greystone Financial Group LLC purchased a new position in shares of UnitedHealth Group during the third quarter valued at approximately $120,000. Institutional investors own 85.43% of the company’s stock.
UNH has been the subject of several research reports. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $287.00 price objective for the company in a report on Sunday, July 15th. Goldman Sachs Group reissued a “buy” rating and set a $277.00 price objective on shares of UnitedHealth Group in a report on Tuesday, July 17th. Royal Bank of Canada boosted their price objective on shares of UnitedHealth Group from $282.00 to $284.00 and gave the company a “$255.42” rating in a report on Wednesday, July 18th. Citigroup boosted their price objective on shares of UnitedHealth Group from $275.00 to $288.00 and gave the company a “$255.42” rating in a report on Wednesday, July 18th. Finally, Morgan Stanley upped their target price on shares of UnitedHealth Group from $277.00 to $278.00 and gave the company a “$255.42” rating in a report on Wednesday, July 18th. One research analyst has rated the stock with a hold rating, twenty-two have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $289.41.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.30 by $0.11. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. The firm had revenue of $56.56 billion during the quarter, compared to analyst estimates of $56.34 billion. During the same quarter in the prior year, the business earned $2.66 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.4% on a year-over-year basis. Research analysts anticipate that UnitedHealth Group Inc will post 12.81 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 13th. Shareholders of record on Monday, December 3rd will be given a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 1.30%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 35.75%.
In other news, Director Richard T. Burke sold 20,000 shares of the firm’s stock in a transaction dated Wednesday, September 12th. The shares were sold at an average price of $263.41, for a total value of $5,268,200.00. Following the completion of the sale, the director now owns 1,720,112 shares in the company, valued at approximately $453,094,701.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP D Ellen Wilson sold 15,393 shares of the firm’s stock in a transaction dated Friday, August 24th. The stock was sold at an average price of $264.29, for a total transaction of $4,068,215.97. Following the completion of the sale, the executive vice president now owns 66,402 shares of the company’s stock, valued at approximately $17,549,384.58. The disclosure for this sale can be found here. Insiders have sold 69,568 shares of company stock valued at $18,539,877 in the last quarter. 0.87% of the stock is owned by company insiders.
COPYRIGHT VIOLATION NOTICE: “UnitedHealth Group Inc (UNH) Shares Sold by Kays Financial Advisory Corp ADV” was originally posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this report on another domain, it was copied illegally and republished in violation of US and international copyright & trademark legislation. The legal version of this report can be accessed at https://sportsperspectives.com/2018/11/10/unitedhealth-group-inc-unh-shares-sold-by-kays-financial-advisory-corp-adv.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: How Do Tariffs Affect Trade Balances?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.